NKTR
NKTR
US6402683063
Nektar Therapeutics
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.41B EUR
2.38B EUR
2.12B EUR
861.62M EUR
Enterprise Value
844.63M EUR
2.42B EUR
2.05B EUR
932.25M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-4.04x
--
--
--
Price to Sales
25.75x
43.65x
38.12x
19.24x
Price to Book
1.56x
2.64x
3.68x
9.59x
EV/Revenue
15.47x
44.37x
36.92x
20.82x
EV/EBITDA
-6.5x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-9.59%
-9.82%
-9.62%
-18.53%
ende